LabCorp (NYSE:LH) needs a little more time to close its $85 million acquisition of Orchid Cellmark (NASDAQ:ORCH). The Burlington, North Carolina-based provider of laboratory services said Monday it has extended its offer for Orchid as it continues to work with the Federal Trade Commission to gain the regulator’s approval of the deal. LabCorp in April […]
LabCorp‘s (NYSE:LH) deadline to buy DNA testing services firm Orchid Cellmark (NASDAQ:ORCH) has been extended to July 15, the third extension for the deal in the last month. The Burlington, North Carolina-based diagnostics and laboratory services company in April had announced a definitive agreement to buy Orchid in a deal valued at more than $85 million. […]
Munck Wilson Mandala Partner Greg Howison shared his perspective on some of the legal ramifications around AI, IP, connected devices and the data they generate, in response to emailed questions.
Diagnostics technologies and lab services company LabCorp (NYSE:LH) is acquiring Clearstone Central Laboratories to boost the company’s capabilities and global reach providing services for clinical trials. Burlington, North Carolina-based LabCorp announced the definitive agreement on Wednesday, though the company did not disclose any financial terms of its proposed acquisition of privately held Clearstone. The companies […]
Diagnostic technologies and genomic testing company LabCorp will buy DNA testing services company Orchid Cellmark in a deal valued at $85.4 million. LabCorp (NYSE:LH) said that the definitive agreement calls for the Burlington, North Carolina-based company to acquire all of the outstanding shares of Orchid (NASDAQ:ORCH) for $2.80 per share. That’s 39 percent more than […]
The University of Minnesota has licensed a test for lupus to Laboratory Corporation of America Holdings (NYSE:LH). Developed by Emily Baechler Gillespie, an assistant professor of medicine at the university's medical school, the test can help doctors proactively treat symptoms of lupus, a painful autoimmune disease.